QHSLab and SDSU receive NSF invitation to submit STTR application for AIR-GUIDDE technology

QHSLab, Inc.

NSF invites QHSLab and South Dakota State University to submit full Phase I STTR application for AIR-GUIDDE drug delivery platform.
Potential NSF funding: Phase I grants up to $305,000; Phase II up to $1.25 million.
AIR-GUIDDE uses CFD modeling to accelerate development and target the $2.6B respiratory drug market.
Project synergizes with QHSLab's existing digital medicine platforms and is non-dilutive to core business.
CEO Troy Grogan says initiative validates company's innovation strategy and is fully aligned with growth plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.